Developer behind Mace’s King’s Cross life sciences building working with agents to find new occupiers after end-user pulled out last year

By Dave Rogers2026-04-27T12:01:00

Sisk saw £110m fit out contract pulled following decision by US drug maker Merck

The developer behind a life sciences building in London that a US drugs maker changed its mind about moving into has said it is speaking to would-be occupiers as Mace prepares to finish up its shell and core contract later this spring.

Already registered? Login here

To continue enjoying Building.co.uk, sign up for free guest access

Existing subscriber? LOGIN

Stay at the forefront of thought leadership with news and analysis from award-winning journalists. Enjoy company features, CEO interviews, architectural reviews, technical project know-how and the latest innovations.

Limited access to building.co.uk
Breaking industry news as it happens
Breaking, daily and weekly e-newsletters

Get your free guest access SIGN UP TODAY

Subscribe now for unlimited access

Subscribe to Building today and you will benefit from:

Unlimited access to all stories including expert analysis and comment from industry leaders
Our league tables, cost models and economics data
Our online archive of over 10,000 articles
Building magazine digital editions
Building magazine print editions
Printed/digital supplements

Subscribe now for unlimited access.

View our subscription options and join our community